Transplantation is an exciting and rapidly expanding field of clinical medicine with great potential for curing human disease. In addition, because of its intimate association with immunology, this field provides an opportunity for fertile interaction between basic scientists and clinicians. The availability of outstanding teams of M.D. and Ph.D. scientists devoted to all aspects of transplantation, from the most basic molecular level to the actual clinical transplants, make the Massachusetts General Hospital/Harvard Medical School a unique environment to foster such interactions. The purpose of this research program is to train young scientists and physician scientists in basic research in a wide variety of topics related to transplantation biology with an emphasis on immunological mechanisms in a multi-disciplinary environment. Participating faculty members with diverse but complementary research interests, a successful record of collaboration, and a commitment to training young investigators, have been assembled to provide trainees with exposure to topics related to transplantation immunology including immunogenetics, tolerance induction, antigen processing and presentation, gene therapy, adhesion molecules, bone marrow transplantation (BMT), regulation of lymphocyte development, pathology of graft rejection, complement biology, autoimmune disease, dendritic cell biology, chemokines and lymphocyte trafficking, B cell biology, mucosal immunology and xenotransplantation. The major goal of this program is to produce outstanding independent investigators capable of addressing fundamental questions in the field of transplantation. Pre-doctoral trainees will be selected from students currently enrolled in the Immunology Program at Harvard University's Division of Medical Sciences who express an interest in pursuing their thesis research in the field of transplantation immunology. Training for pre-doctoral students will take approximately 4 years. Support is requested for 3 pre-doctoral trainees per year, distributed between students in their 1st, 2nd, 3rd, or 4th year of thesis research. Postdoctoral trainees currently holding a degree of MD, PhD, or MD/PhD will be selected based on having outstanding potential to pursue a career in research and teaching and a commitment to independent investigation. Training will require 2-3 years. Support is requested for 6 postdoctoral trainees in years 1-5.
| Fan, Martin Y; Low, Jun Siong; Tanimine, Naoki et al. (2018) Differential Roles of IL-2 Signaling in Developing versus Mature Tregs. Cell Rep 25:1204-1213.e4 |
| Fan, Martin Y; Turka, Laurence A (2018) Immunometabolism and PI(3)K Signaling As a Link between IL-2, Foxp3 Expression, and Suppressor Function in Regulatory T Cells. Front Immunol 9:69 |
| Boneschansker, Leo; Jorgensen, Julianne; Ellett, Felix et al. (2018) Convergent and Divergent Migratory Patterns of Human Neutrophils inside Microfluidic Mazes. Sci Rep 8:1887 |
| Patel, Madhukar S; Louras, Nathan; Vagefi, Parsia A (2017) Liver xenotransplantation. Curr Opin Organ Transplant 22:535-540 |
| Shah, J A; Patel, M S; Elias, N et al. (2017) Prolonged Survival Following Pig-to-Primate Liver Xenotransplantation Utilizing Exogenous Coagulation Factors and Costimulation Blockade. Am J Transplant 17:2178-2185 |
| Climov, Mihail; Medeiros, Erika; Farkash, Evan A et al. (2016) Bioengineered Self-assembled Skin as an Alternative to Skin Grafts. Plast Reconstr Surg Glob Open 4:e731 |
| Borges, Christopher M; Reichenbach, Dawn K; Kim, Beom Seok et al. (2016) Regulatory T cell expressed MyD88 is critical for prolongation of allograft survival. Transpl Int 29:930-40 |
| Boneschansker, Leo; Nakayama, Hironao; Eisenga, Michele et al. (2016) Netrin-1 Augments Chemokinesis in CD4+ T Cells In Vitro and Elicits a Proinflammatory Response In Vivo. J Immunol 197:1389-98 |
| Climov, Mihail; Matar, Abraham J; Farkash, Evan A et al. (2016) Survival of Allogeneic Self-Assembled Cultured Skin. Transplantation 100:2071-8 |
| Madariaga, Maria Lucia L; Spencer, Philip J; Shanmugarajah, Kumaran et al. (2016) Effect of tolerance versus chronic immunosuppression protocols on the quality of life of kidney transplant recipients. JCI Insight 1: |
Showing the most recent 10 out of 62 publications
